ID   EPHA8_RAT               Reviewed;         372 AA.
AC   P29321;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-1992, sequence version 1.
DT   24-JUL-2024, entry version 172.
DE   RecName: Full=Ephrin type-A receptor 8;
DE            EC=2.7.10.1;
DE   AltName: Full=EPH- and ELK-related kinase;
DE   AltName: Full=Tyrosine-protein kinase receptor EEK;
DE   Flags: Fragment;
GN   Name=Epha8; Synonyms=Eek;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Brain;
RX   PubMed=1648701;
RA   Chan J., Watt V.M.;
RT   "eek and erk, new members of the eph subclass of receptor protein-tyrosine
RT   kinases.";
RL   Oncogene 6:1057-1061(1991).
CC   -!- FUNCTION: Receptor tyrosine kinase which binds promiscuously GPI-
CC       anchored ephrin-A family ligands residing on adjacent cells, leading to
CC       contact-dependent bidirectional signaling into neighboring cells. The
CC       signaling pathway downstream of the receptor is referred to as forward
CC       signaling while the signaling pathway downstream of the ephrin ligand
CC       is referred to as reverse signaling. The GPI-anchored ephrin-A EFNA2,
CC       EFNA3, and EFNA5 are able to activate EPHA8 through phosphorylation.
CC       With EFNA5 may regulate integrin-mediated cell adhesion and migration
CC       on fibronectin substrate but also neurite outgrowth. During development
CC       of the nervous system also plays a role in axon guidance. Downstream
CC       effectors of the EPHA8 signaling pathway include FYN which promotes
CC       cell adhesion upon activation by EPHA8 and the MAP kinases in the
CC       stimulation of neurite outgrowth (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- SUBUNIT: Heterotetramer upon binding of the ligand. The heterotetramer
CC       is composed of an ephrin dimer and a receptor dimer. Oligomerization is
CC       probably required to induce biological responses. May also form
CC       heterodimers with other ephrin receptors. Interacts with FYN; possible
CC       downstream effector of EPHA8 in regulation of cell adhesion. Interacts
CC       with PIK3CG; regulates integrin-mediated cell adhesion to substrate.
CC       Interacts with TIAM1; regulates clathrin-mediated endocytosis of EPHA8.
CC       Interacts with ANKS1A and ANKS1B; EPHA8 kinase activity-independent but
CC       stimulated by EPHA8 ubiquitination (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:O09127};
CC       Single-pass type I membrane protein {ECO:0000255}. Cell projection
CC       {ECO:0000250|UniProtKB:O09127}. Early endosome membrane
CC       {ECO:0000250|UniProtKB:O09127}. Note=Undergoes clathrin-mediated
CC       endocytosis upon EFNA5-binding and is targeted to early endosomes.
CC       {ECO:0000250|UniProtKB:O09127}.
CC   -!- TISSUE SPECIFICITY: Most abundant in brain.
CC   -!- PTM: Phosphorylated. Phosphorylation is stimulated upon binding of its
CC       ligands including EFNA2, EFNA3 and EFNA5. Autophosphorylation on Tyr-
CC       206 modulates tyrosine kinase activity (By similarity). {ECO:0000250}.
CC   -!- PTM: Ubiquitinated. Ubiquitination by CBL regulates the receptor
CC       stability and activity through proteasomal degradation. ANKS1A prevents
CC       ubiquitination and degradation (By similarity). {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X59290; CAA41979.1; -; mRNA.
DR   PIR; S23363; S23363.
DR   AlphaFoldDB; P29321; -.
DR   SMR; P29321; -.
DR   STRING; 10116.ENSRNOP00000017559; -.
DR   PaxDb; 10116-ENSRNOP00000017559; -.
DR   UCSC; RGD:708543; rat.
DR   AGR; RGD:708543; -.
DR   RGD; 708543; Epha8.
DR   eggNOG; KOG0196; Eukaryota.
DR   InParanoid; P29321; -.
DR   PhylomeDB; P29321; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043005; C:neuron projection; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0043235; C:receptor complex; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005003; F:ephrin receptor activity; ISS:UniProtKB.
DR   GO; GO:0005004; F:GPI-linked ephrin receptor activity; ISS:UniProtKB.
DR   GO; GO:0019838; F:growth factor binding; ISO:RGD.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0007411; P:axon guidance; ISS:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0071372; P:cellular response to follicle-stimulating hormone stimulus; ISO:RGD.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0031175; P:neuron projection development; ISS:UniProtKB.
DR   GO; GO:0016322; P:neuron remodeling; ISS:UniProtKB.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISS:UniProtKB.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISS:UniProtKB.
DR   GO; GO:0030155; P:regulation of cell adhesion; ISS:UniProtKB.
DR   GO; GO:0033628; P:regulation of cell adhesion mediated by integrin; ISS:UniProtKB.
DR   GO; GO:0006929; P:substrate-dependent cell migration; ISS:UniProtKB.
DR   CDD; cd09550; SAM_EPH-A8; 1.
DR   Gene3D; 1.10.150.50; Transcription Factor, Ets-1; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR050449; Ephrin_rcpt_TKs.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   PANTHER; PTHR46877; EPH RECEPTOR A5; 1.
DR   PANTHER; PTHR46877:SF7; EPHRIN TYPE-A RECEPTOR 8; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   Pfam; PF00536; SAM_1; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00454; SAM; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   SUPFAM; SSF47769; SAM/Pointed domain; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding; Cell adhesion; Cell membrane; Cell projection;
KW   Developmental protein; Endosome; Kinase; Membrane; Neurogenesis;
KW   Nucleotide-binding; Phosphoprotein; Receptor; Reference proteome;
KW   Transferase; Tyrosine-protein kinase; Ubl conjugation.
FT   CHAIN           <1..372
FT                   /note="Ephrin type-A receptor 8"
FT                   /id="PRO_0000160273"
FT   DOMAIN          2..263
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          297..372
FT                   /note="SAM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00184"
FT   MOTIF           370..372
FT                   /note="PDZ-binding"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        127
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         8..16
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         34
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         206
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:O09127"
FT   NON_TER         1
SQ   SEQUENCE   372 AA;  41233 MW;  C8FDCFB5A6904BA5 CRC64;
     RIHIEKIIGS GESGEVCYGR LQVPGQRDVP VAIKALKAGY TERQRQDFLR EAAIMGQFDH
     PNIIRLEGVV TRGRLAMIVT EYMENGSLDA FLRTHDGQFT ILQLVGMLKG VGAGMRYLSD
     LGYIHRDLAA RNILVDGRLV CKVSDFGLSR ALEDDPEAAY TTAGGKIPIR WTAPEAIAFR
     TFSSASDVWS FGVVMWEVLA YGERPYWNMT NQDVISSVEE GYRLPAPMGC PRALHQLMLD
     CWHKDRAQRP RFSHVVSVLE ALVHSPESLR ATATVSRCPA PAFARSCFDL RAGGNGNGDL
     TVGDWLDSIR MGRYRDHFAA GGYSSLGMVL HMNAQDVRAL GITLMGHQKK ILGSIQTMRS
     QLSCTQGPRR HL
//
